Table 2 Bcl-2 immunoreactivity in ovarian tissue sections.
From: Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation
| Â | Â | % Positive Epithelium (n) | % Positive Stroma (n) | ||||
|---|---|---|---|---|---|---|---|
|  | Total | Total | ≤ 50% | > 50% | Total | ≤ 50% | > 50% |
Normal | 2 | 50 (1) | 100 (2) | 0 | 100 (2) | 0 | 100 (2) |
Normal within Benign | 5 | 100 (5) | 100 (5) | 0 | --- | --- | --- |
Normal within Cancer | 4 | 100 (4) | 50 (2) | 50 (2) | --- | --- | --- |
Total Normal | 11 | 91 (10) | 82 (9) | 18 (2) | 100 (2) | 0 | 100 (2) |
Cysts | 4 | 100 (4) | 25 (1) | 75 (3) | 50 (2) | 75 (3) | 25 (1) |
Cystadenomas | 13 | 100 (13) | 38 (5) | 62 (8) | 92 (12) | 62 (8) | 38 (5) |
Total Benign | 17 | 100 (17) | 35 (6) | 65 (11) | 82 (14) | 65 (11) | 35 (6) |
WD | 3 | 100 (3) | 33 (1) | 67 (2) | 100 (3) | 66 (2) | 33 (1) |
MD | 6 | 100 (6) | 67 (4) | 33 (2) | 17 (1) | 83 (5) | 17 (1) |
PD | 19 | 68 (13) | 79 (15) | 21 (4) | 68 (13) | 95 (18) | 5 (1) |
Total Cancerous | 28 | 79 (22) | 71 (20) | 29 (8) | 61 (17) | 89 (25) | 11 (3) |